Radiation Segmentetectomy for Very Early and Early Stage Hepatocellular Carcinoma
Edward Kim, MD, discusses a multidisciplinary study by researchers at Icahn Mount Sinai finding that radiation segmentectomy may be an effective treatment for very early- to early-stage hepatocellular carcinoma (the most common type of primary liver cancer) that cannot be treated surgically or thermally. He said, “We have used radiation segmentectomy at Mount Sinai for more than a decade, and our patients have benefited tremendously as a result. It is an extremely well-tolerated, easily replicated, and reproducible technique. The challenge is that there is a general lack of awareness about this technology and how well it works. We decided to undertake the first-ever prospective study because we participated in the initial retrospective study of radiation segmentectomy, and we could generate data that would demonstrate its safety and efficacy.”